Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity. [electronic resource]
Producer: 20180124Description: 6 p. digitalISSN:- 2041-1723
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cytokines -- drug effects
- Drug Delivery Systems
- Granzymes -- drug effects
- Interleukin-2 -- pharmacology
- Killer Cells, Natural -- drug effects
- Liposomes
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Melanoma, Experimental
- Mice
- Nanoparticles
- Skin Neoplasms
- T-Lymphocytes, Cytotoxic -- drug effects
- Tumor Microenvironment -- drug effects
- Tumor Necrosis Factor Receptor Superfamily, Member 9 -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.